Natural compounds with aromatase inhibitory activity: An update

Planta Medica

Volumn 76, Issue 11, 2010, Pages 1087-1093

  Balunas, Marcy J ^a,b,c,d   Kinghorn, A Douglas ^e  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Instituto de Investigaciones Cientficas y Servicios de Alta Tecnologa   (Australia)

^d SMITHSONIAN TROPICAL RESEARCH INSTITUTE   (Panama)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

aromatase; breast cancer; fungi; marine organisms; natural compounds; plants

Indexed keywords

ALKALOID; AROMATASE; AROMATASE INHIBITOR; CHALCONE; COUMARIN; FATTY ACID; FLAVANONE; FLAVONOID; ISOFLAVONE; NATURAL PRODUCT; TERPENOID; XANTHONE DERIVATIVE;

BREAST CANCER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL LINE; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MICE;

FUNGI;

EID: 77955067875     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250169     Document Type: Review

References (44)

1. Parkin D M., Fernandez L M. Use of statistics to assess the global burden of breast cancer. Breast J 2006 12 (Suppl.1) S70-S80
2. Igene H. Global health inequalities and breast cancer: an impending public health problem for developing countries. Breast J 2008 14 428-434
3. Chlebowski R, Cuzick J, Amakye D, Bauerfeind I, Buzdar A, Chia S, Cutuli B, Linforth R, Maass N, Noguchi S, Robidoux A, Verma S, Hadji P. Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer. Breast 2009 18 (Suppl.2) S1-S11
4. Gibson L, Lawrence D, Dawson C, Bliss J. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Cochrane Database Syst Rev 2009 CD003370
5. Chlebowski R T., Anderson G L., Geller M, Col N. Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy use. Clin Breast Cancer 2006 6 (Suppl.2) S58-S64
6. Goss P E., Qi S L., Hu H Q., Cheung A M. The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model. Breast Cancer Res Treat 2007 103 293-302
7. Balunas M J., Su B, Brueggemeier R W., Kinghorn A D. Natural products as aromatase inhibitors. Anticancer Agents Med Chem 2008 8 646-682
8. Zhao J, Dasmahapatra A K., Khan S I., Khan I A. Anti-aromatase activity of the constituents from damiana (Turnera diffusa). J Ethnopharmacol 2008 120 387-393
9. Ye L, Gho W M., Chan F L., Chen S, Leung L K. Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase. Int J Cancer 2009 124 1028-1036
10. Wang Y, Man Gho W, Chan F L., Chen S, Leung L K. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Br J Nutr 2008 99 303-310
11. Su S L., Duan J A., Tang Y P., Zhang X, Yu L, Jiang F R., Zhou W, Luo D, Ding A W. Isolation and biological activities of neomyrrhaol and other terpenes from the resin of Commiphora myrrha. Planta Med 2009 75 351-355
12. Balunas M J., Su B, Brueggemeier R W., Kinghorn A D. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J Nat Prod 2008 71 1161-1166
13. Yang N Y., Li K, Yang Y F., Li Y H. Aromatase inhibitory fatty acid derivatives from the pollen of Brassica campestris L. var. oleifera DC. J Asian Nat Prod Res 2009 11 132-137
14. Balunas M J., Su B, Riswan S, Fong H H. S., Brueggemeier R W., Pezzuto J M., Kinghorn A D. Isolation and characterization of aromatase inhibitors from Brassaiopsis glomerulata (Araliaceae). Phytochem Lett 2009 2 29-33
15. Balunas M J., Su B, Landini S, Brueggemeier R W., Kinghorn A D. Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay. J Nat Prod 2006 69 700-703
16. Paoletta S, Steventon G B., Wildeboer D, Ehrman T M., Hylands P J., Barlow D J. Screening of herbal constituents for aromatase inhibitory activity. Bioorg Med Chem 2008 16 8466-8470
17. Endringer D C., Guimaraes K G., Kondratyuk T P., Pezzuto J M., Braga F C. Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara. J Nat Prod 2008 71 1082-1084
18. Ito A, Shamon L A., Yu B, Mata-Greenwood E, Lee S K., van Breemen R B., Mehta R G., Farnsworth N R., Fong H H. S., Pezzuto J M., Kinghorn A D. Antimutagenic constituents of Casimiroa edulis with potential cancer chemopreventive activity. J Agric Food Chem 1998 46 3509-3516
19. Maiti A, Reddy P V., Sturdy M, Marler L, Pegan S D., Mesecar A D., Pezzuto J M., Cushman M. Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities. J Med Chem 2009 52 1873-1884
20. McNulty J, Nair J J., Bollareddy E, Keskar K, Thorat A, Crankshaw D J., Holloway A C., Khan G, Wright G D., Ejim L. Isolation of flavonoids from the heartwood and resin of Prunus avium and some preliminary biological investigations. Phytochemistry 2009 70 2040-2046
21. Chomcheon P, Wiyakrutta S, Sriubolmas N, Ngamrojanavanich N, Kengtong S, Mahidol C, Ruchirawat S, Kittakoop P. Aromatase inhibitory, radical scavenging, and antioxidant activities of depsidones and diaryl ethers from the endophytic fungus Corynespora cassiicola L36. Phytochemistry 2009 70 407-413
22. Antia B S., Pansanit A, Ekpa O D., Ekpe U J. M., Chulabhorn, Kittakoop P. Alpha-glucosidase inhibitory, aromatase inhibitory, and antiplasmodial activities of a biflavonoid GB1 from Garcinia kola stem bark. Planta Med 2010 76 276-277
23. Pontius A, Krick A, Mesry R, Kehraus S, Foegen S E., Muller M, Klimo K, Gerhauser C, Konig G M. Monodictyochromes A and B, dimeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis. J Nat Prod 2008 71 1793-1799
24. Liu J, He C, Zhou K, Wang J, Kang J X. Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells. Biochem Biophys Res Commun 2009 378 174-178
25. Flemming J, Madarnas Y, Franek J A. Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review. Breast Cancer Res Treat 2009 115 255-268
26. Qiao Y, Cao J, Xie L, Shi X. Cell growth inhibition and gene expression regulation by ()-epigallocatechin-3-gallate in human cervical cancer cells. Arch Pharm Res 2009 32 1309-1315
27. Ye L, Chan M Y., Leung L K. The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway. Mol Cell Endocrinol 2009 302 73-80
28. Sassi-Messai S, Gibert Y, Bernard L, Nishio S, Ferri Lagneau K F., Molina J, Andersson-Lendahl M, Benoit G, Balaguer P, Laudet V. The phytoestrogen genistein affects zebrafish development through two different pathways. PLoS One 2009 4 e4935
29. 9- tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase. Toxicology 2009 259 25-32
30. Kellis Jr J T., Vickery L E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984 225 1032-1034
31. Le Bail J C., Champavier Y, Chulia A J., Habrioux G. Effects of phytoestrogens on aromatase, 3 - and 17 -hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci 2000 66 1281-1291
32. Le Bail J C., Pouget C, Fagnere C, Basly J P., Chulia A J., Habrioux G. Chalcones are potent inhibitors of aromatase and 17 -hydroxysteroid dehydrogenase activities. Life Sci 2001 68 751-761
33. Saarinen N, Joshi S C., Ahotupa M, Li X, Ammala J, Makela S, Santti R. No evidence for the in vivo activity of aromatase-inhibiting flavonoids. J Steroid Biochem Mol Biol 2001 78 231-239
34. Lee D, Bhat K P. L., Fong H H. S., Farnsworth N R., Pezzuto J M., Kinghorn A D. Aromatase inhibitors from Broussonetia papyrifera. J Nat Prod 2001 64 1286-1293
35. van Meeuwen J A., Nijmeijer S, Mutarapat T, Ruchirawat S, de Jong P C., Piersma A H., van den Berg M. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts a comparative study. Toxicol Appl Pharmacol 2008 228 269-273
36. Monteiro R, Becker H, Azevedo I, Calhau C. Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. J Agric Food Chem 2006 54 2938-2943
37. Monteiro R, Faria A, Azevedo I, Calhau C. Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J Steroid Biochem Mol Biol 2007 105 124-130
38. Sanderson J T., Hordijk J, Denison M S., Springsteel M F., Nantz M H., van den Berg M. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci 2004 82 70-79
39. Blanco J G., Gil R R., Bocco J L., Meragelman T L., Genti-Raimondi S, Flury A. Aromatase inhibition by an 11,13-dihydro derivative of a sesquiterpene lactone. J Pharmacol Exp Ther 2001 297 1099-1105
40. Kanamaru T, Nozaki Y M., Masayuki M. TAN-1085 and its aglycon as angiogenesis and aromatase inhibitors and their manufacture with Streptomyces species. Japanese Patent: JP02-289532. 1990
41. Santen R J., Brodie H, Simpson E R., Siiteri P K., Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev 2009 30 343-375
42. Bulun S E., Lin Z, Zhao H, Lu M, Amin S, Reierstad S, Chen D. Regulation of aromatase expression in breast cancer tissue. Ann NY Acad Sci 2009 1155 121-131
43. Ghosh D, Griswold J, Erman M, Pangborn W. X-ray structure of human aromatase reveals an androgen-specific active site. J Steroid Biochem Mol Biol 2010 118 197-202
44. Wong S T. Emerging treatment combinations: integrating therapy into clinical practice. Am J Health Syst Pharm 2009 66 S9-S14